Finally, TRAF7 was associated with carcinogenic activity in several cancer types, including KIRC (OS: n = 531, p = 0.003, Supplementary Fig. 2P), LGG (OS: n = 524, p < 0.001, Supplementary Fig. 2Q), LUSC (OS: n = 493, p = 0.028, Supplementary Fig. 2R), Ovarian Serous Cystadenocarcinoma (OV) (OS: n = 378, p = 0.036, Supplementary Fig. 2S), PAAD (OS: n = 177, p = 0.037, Supplementary Fig. 2 T), and SKCM (OS: n = 457, p = 0.002, Supplementary Fig. 2U). Here, TRAF7 is linked to cancer.